$IBB News
Last published 1w ago
- 1w agoGMABABBVMRKJNJ+4A little-known biotech’s high-stakes cancer bet just paid off and its shares doubledCNBCGenmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
- 1mo agoNVSNVOAZN-GBGSK+3Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar dealsCNBCWestern biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
- 4mo agoGSKNUVLXBIIBB+3Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBCCNBCBiopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.
- 1y agoALTIBBNBIAltimmune Added to Nasdaq Biotechnology IndexGlobeNewswireGAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a clinical-stage biopharmaceutical company, today announced that it will be added to the Nasdaq Biotechnology Index (NASDAQ:NBI)
- 3y agoIBBTARSNBITarsus Added to NASDAQ Biotechnology IndexGlobeNewswireIRVINE, Calif., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for
- 4y agoAQSTIBBNBIAquestive Therapeutics Added to NASDAQ Biotechnology IndexGlobeNewswireWARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients' unmet needs and solve therapeutic probl
- 4y agoFBIOIBBMBIONBIMustang Bio Added to the NASDAQ Biotechnology IndexGlobeNewswireWORCESTER, Mass., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematol
- 4y agoGRCLIBBNBIGracell Biotechnologies Selected for Addition to NASDAQ Biotechnology IndexPR NewswireSUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Dec. 16, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ:GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and aff
- 4y agoCRISIBBNBICuris to be Added to the Nasdaq Biotechnology Index and the iShares Biotechnology ETFPR NewswireLEXINGTON, Mass., Dec. 15, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has been selected for addition to the Nasdaq Bio
- 5y ago.DJI.SPX.IXICGOOGL+18Stocks could be volatile in week ahead amid turbulence from cryptocurrencyCNBCThe down and up trading pattern of the past two weeks suggests stocks could continue to be volatile in the week ahead.
- 5y agoBLKIBBSOXXBlackRock Announces Product Updates to Two iShares ETFsBusiness WireBlackRock, Inc. (NYSE:BLK) today announced product enhancements to two iShares ETFs as part of an ongoing process to periodically review its product lineup. No action is necessary for investors in the impacted ETFs and no capital gains distributions
- 5y agoPRVBNBIIBBProvention Bio Announces Addition to NASDAQ Biotechnology IndexPR NewswireProvention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced...
- 5y agoPSTXNBIIBBPoseida Therapeutics Added to NASDAQ Biotechnology IndexPR NewswirePoseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to ...
- 5y agoGMDANBIIBBGamida Cell Added to NASDAQ Biotechnology IndexBusiness WireBOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 21, 2020.
- 5y agoIMUXNBIIBBImmunic, Inc. Added to NASDAQ Biotechnology IndexPR NewswireImmunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at...
- 6y agoAZN-GBXLVIBBXBI+4Health care has 'more room to run' after hitting record highs, ETF analyst saysCNBCThe health-care trade can continue to work as biotechnology and pharmaceutical companies get closer to finding treatments and a possible vaccine for Covid-19, says Todd Rosenbluth, senior director of ETF and mutual fund research at CFRA.
- 6y agoIBBXBIMissed the biotech breakout? These stocks in the industry are still set to run, MKM saysCNBCBiotechnology stocks have ripped higher in 2020 and some investors might have missed their chance to capitalize on the surge.
- 6y agoIBBMRNAGILDAMGN+3Tread carefully if you're buying biotech stocks, traders say as group nears all-time highsCNBCAs biotechnology stocks surge, traders advice investors to be selective.
- 6y agoFDNIBBIWMThe stock market is flashing some troubling signs, chart analysts sayCNBCThe stock market is flashing warning signs, as investors re-evaluate the economy's potential to recover from the coronavirus shutdowns.
- 6y agoHOLXDGXINCYXLV+8Investor hope pushes biotech stocks to best monthly gain in two decadesCNBCStrong gains in April pushed the health care sector near year highs on hopes for new Covid treatments.
- 6y agoIBBGILDMRNABiotech stocks surge as people are 'hungry' for good news on the coronavirusCNBCBiotech stocks surged Friday after new details on a closely watched clinical trial lifted hopes that scientists may be close to a treatment for the coronavirus.
- 6y agoVRTXIBBVertex Pharma 'got dinged' after Democratic debate, creating a 'very buyable dip,' Jim Cramer saysCNBC"As much as I hate to chase, I honestly don't think you're that late to the party with Vertex if you buy it at these levels," the "Mad Money" host says.
- 6y agoCGENIBBCompugen Added to the NASDAQ Biotechnology IndexPR NewswireCompugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has...
- 6y agoCSTLNBIIBBCastle Biosciences Added to NASDAQ Biotechnology IndexBusiness WireFRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL) today announced that the Company was recently added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to the market open on Monday, December 23, 2019.
- 6y agoIBBCurrent Equity Rally Can Continue to Year End: SGMC CEOBloomberg
- 8y agoAUPHNBIIBBAurinia Pharmaceuticals Added to the NASDAQ Biotech IndexBusiness WireVICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) announced today that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq:^NBI), which will become effective prior to market open on Monday, December 18, 2017.
- 11y agoAERINBIIBBAerie Pharmaceuticals Added to NASDAQ Biotechnology Index (NBI)Business WireBEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today that it has been selected for addition to the NA ...
- 11y agoFMINBIIBBFoundation Medicine to Be Added to NASDAQ Biotechnology IndexBusiness WireCAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the Company will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective prior to the market open on Monday, December 22, 2014.
- 14y agoCLDXIBBCelldex Therapeutics Added to Nasdaq Biotechnology IndexBusiness WireNEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the Company will be added to the NASDAQ Biotechnology Index® (NBI), effective prior to market open on Monday, May 21, 2012. The NBI includes biotechnology or pharmaceutical companies listed exclusively on the NASDAQ Global Select Market or on the NASDAQ Global Market that meet predetermined eligibility ...
- 14y agoINFIIBBInfinity Added to NASDAQ Biotechnology IndexBusiness WireCAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company will be added to the NASDAQ Biotechnology Index® (NBI). The semi-annual re-ranking of the index will become effective prior to market open on Monday, May 21, 2012.